the phase II study of green tea on advanced pancreatobiliary tract cancers

the phase II study of green tea on advanced pancreatobiliary tract cancers - the effect of green tea on advanced pancreatobiliary tract cancers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013713

Enrollment

Registered

2014-05-01

Start date

2014-05-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced pancreatobiliary tract cancers

Interventions

anti-cancer agents

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: WBC 3500mm3> 12,0003< Neutrophil 2000mm3> Hb>9.0 Piatelet>80,000 T-Bil<2.0 AST<150 ALT<150 Creatinin<2.0 Ccr<50

Exclusion criteria

Exclusion criteria: Diarrhea Multiple primaries Active infectious disease HBsAg(+) Allergy Pregnancy

Design outcomes

Primary

Measure	Time frame
the response rate	—

Countries

Japan

Contacts

Public ContactShuichi Iwahashi

Tokushima University Department of Surgery

iwahashi@clin.med.tokushima-u.ac.jp088-633-7139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026